Coastal Carolina Research Center, Inc.

Mt. Pleasant, South Carolina 29464

0 studies enrolling now · 22 studies all time

What they study most

Acute Treatment of Migraine, Anthrax, Bird Flu, Chronic Migraine, Depressive Disorder, Major, Hot Flashes, Influenza, Major Depressive Disorder, Male Hypogonadism, Mammographic Breast Density, Migraine, Migraine Disorders

Studies at this site

• VELOCITY: An Anthrax Vaccine Clinical Study — Completed
• A Study of Cytisinicline for Smoking Cessation in Adult Smokers — Completed
• Safety and Immunogenicity of Replication-Competent Adenovirus 4-vectored Vaccine for Avian Influenza H5N1 — Completed
• Dose Ranging Study of Rimegepant (BMS-927711) for the Acute Treatment of Migraine — Completed
• Trial of 4-Hydroxytamoxifen (4-OHT) Gel in Women Aimed at Reducing Dense Breast Tissue — Stopped early
• Evaluation of Galcanezumab in the Prevention of Chronic Migraine — Completed
• A Trial to Investigate Efficacy, Safety and Tolerability of FE 201836 for Nocturia Due to Nocturnal Polyuria in Adults — Completed
• Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder (MDD) — Completed
• An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine — Completed
• A Study of Galcanezumab (LY2951742) in Adults With Treatment-Resistant Migraine — Completed
• Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder — Completed
• Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study — Completed
• A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis — Completed
• Trial of Cytisine in Adult Smokers — Completed
• A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder — Completed
• A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02) — Completed
• Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute Treatment of Migraine — Completed
• A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache — Completed
• Safety and Efficacy of Intranasal TBS-1 Treatment of Male Hypogonadism — Completed
• Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain — Completed
• Study of NXN 188 for the Treatment of Migraine With Aura — Completed
• Study of Gabapentin Extended Release (G-ER)in the Treatment of Vasomotor (Hot Flashes/Hot Flushes) Symptoms in Postmenopausal Women. — Completed